In PCAF-deficient cervical cancer cell lines, supplementation with metformin was ineffective at restoring H3K9ac levels, indicating that AMPK activation loses its capacity to hyperacetylate H3K9 in the absence of PCAF. This evidence concerns the gene PRKAA1 and cervical cancer.